Choroidal Neovascularization
"Choroidal Neovascularization" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A pathological process consisting of the formation of new blood vessels in the CHOROID.
| Descriptor ID |
D020256
|
| MeSH Number(s) |
C11.941.160.244 C23.550.589.500.145
|
| Concept/Terms |
Choroidal Neovascularization- Choroidal Neovascularization
- Neovascularization, Choroid
- Neovascularization, Choroidal
- Choroidal Neovascularizations
- Choroid Neovascularization
- Choroid Neovascularizations
|
Below are MeSH descriptors whose meaning is more general than "Choroidal Neovascularization".
Below are MeSH descriptors whose meaning is more specific than "Choroidal Neovascularization".
This graph shows the total number of publications written about "Choroidal Neovascularization" by people in this website by year, and whether "Choroidal Neovascularization" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2000 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2012 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 1 | 2 |
| 2016 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Choroidal Neovascularization" by people in Profiles.
-
PRMT5 is a therapeutic target in choroidal neovascularization. Sci Rep. 2023 01 31; 13(1):1747.
-
Soluble very low-density lipoprotein receptor (sVLDLR) inhibits fibrosis in neovascular age-related macular degeneration. FASEB J. 2021 12; 35(12):e22058.
-
Screening Medications for Association with Progression to Wet Age-Related Macular Degeneration. Ophthalmology. 2021 02; 128(2):248-255.
-
Five-Year Real-World Outcomes of Occult and Classic Choroidal Neovascularization: Data From the Fight Retinal Blindness! Project. Am J Ophthalmol. 2019 08; 204:105-112.
-
Therapeutic Effects of PPARa Agonist on Ocular Neovascularization in Models Recapitulating Neovascular Age-Related Macular Degeneration. Invest Ophthalmol Vis Sci. 2017 10 01; 58(12):5065-5075.
-
Targeted Intraceptor Nanoparticle for Neovascular Macular Degeneration: Preclinical Dose Optimization and Toxicology Assessment. Mol Ther. 2017 07 05; 25(7):1606-1615.
-
Diagnostic and Therapeutic Challenges. Retina. 2016 Apr; 36(4):840-5.
-
Effects of core vitrectomy in the treatment of age-related macular degeneration. Acta Ophthalmol. 2014 Aug; 92(5):465-72.
-
Sphingolipids in ocular inflammation. Adv Exp Med Biol. 2014; 801:623-9.
-
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1. Elife. 2013 Jun 18; 2:e00324.